Physical Therapists in Dayton, NJ Accepting Medicare

9 Physical Therapists found. Showing 1 - 9

Oncare Rehab Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 603 Dahlia Cir, Dayton, NJ 08810 Phone: 732-476-4245

Prathibha Gottumukkala Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2245 Us Highway 130 Ste 105, Dayton, NJ 08810 Phone: 732-609-7155    Fax: 609-228-6173

Realign Rehab Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 14 Debra Dr, Dayton, NJ 08810 Phone: 732-995-1288

Vishal Gandhi Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Issac Dr, Dayton, NJ 08810 Phone: 732-829-4490

Epoch Physical Therapy Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 2245 Route 130, Dayton, NJ 08810 Phone: 412-654-3212    Fax: 833-888-7868

Krystina F Cierkowski, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 365 Georges Rd Ste 4, Dayton, NJ 08810 Phone: 732-438-3736

Lynn Fraass, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6 Mill Ln, Dayton, NJ 08810 Phone: 732-329-1655

Devon Shire, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 365 Geroges Rd, Suite 4, Dayton, NJ 08810 Phone: 732-438-3736    Fax: 732-855-9751

Nichole D Fields, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 365 Georges Rd Ste 4, Dayton, NJ 08810 Phone: 732-438-3736    Fax: 732-855-9755

News Archive

Alcresta signs agreement with CFFT to support nutritional status of people with cystic fibrosis

Alcresta, a leading medical nutrition company developing innovative enzyme-based products for individuals with unique nutritional needs battling acute conditions or chronic diseases, today announced the company has signed an agreement with Cystic Fibrosis Foundation Therapeutics (CFFT) to accelerate the development of Alcresta's enzyme-based point-of-care products to support the nutritional status of people with cystic fibrosis (CF).

Patient care violations at Sutter Solano Medical Center pose serious threats to the health and safety of patients

The Centers for Medicare and Medicaid, a federal agency within the U.S. Dept. of Health and Human Services, has concluded an investigation into patient care violations at Sutter Solano Medical Center that pose an "immediate and serious threat to the health and safety of patients."

Schering-Plough announces agreement with Orchid Chemicals & Pharmaceuticals on generic forms of CLARINEX

Schering-Plough Corporation (NYSE: SGP) today announced an agreement with Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma, Inc. ("Orchid"), related to the generic manufacturing of certain formulations of CLARINEX(R) (desloratadine).

DSPA's lurasidone NDA accepted for FDA review

Dainippon Sumitomo Pharma America, Inc., a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd., today announced that the U.S. Food and Drug Administration recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review.

Read more Medical News

› Verified 6 days ago